We will select RNA-binding protein genes of interest and check their expression levels in RNA-seq data.
What are the goals of this project?
Researchers will analyze genetic data in an effort to identify biomarkers and possible therapeutic targets for the treatment of glioblastoma.
What is the impact of this project?
If new biomarkers and targets are identified and verified, it will advance treatment options for patients with glioblastoma.
Why is the CBTN request important to this project?
This work requires robust datasets on pediatric glioblastoma patients, something CBTN is well suited to provide.